SIO Integrative Program
Gateway is focused on funding integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life, especially post-treatment. Grants are generally awarded for a 2-5 year period, with total award amounts generally ranging from $200,000 to $1.5 million.
The application process has a rolling Letter of Intent (LOI) submission which is aggregated four times a year.
- LOI submission – As part of a Letter of Intent (LOI), researchers answer basic questions about fit with Gateway’s mission and funding criteria, and provide contact information, high level information related to the proposed project, a concise summary of the study rationale, current standard of care, an overview of specific aims/objectives, and proposed research design/approach. LOIs are pre-generated/templated applications and must be submitted before the deadline listed on our GMS to be reviewed in upcoming cycle.
- LOI review – LOIs are assigned to scientists on Gateway’s Research and Grants Committee for peer review. The LOIs are reviewed within seven days after the LOI deadline has passed.
- Full Grant invitation to submit – Applicants who demonstrate that their project is in line with Gateway’s mission and are approved by the peer reviewers are invited to submit a Full Grant Application (FGA). Applicants will be given 4-5 weeks to complete a full grant application.
- Full Grant review – Once the full grant application is submitted to Gateway, each application is reviewed by the full Research and Grants Committee at a convened meeting and given a score per the NIH scoring model to indicate funding priority. The most promising grants are presented to Gateway’s Board of Directors.
- Full Grant approval – Gateway’s Board of Directors reviews the promising grants and determines final fiduciary approval of grant awards.